Breast cancer risk assessment in patients who test negative for a hereditary cancer syndrome

Am J Surg. 2020 Mar;219(3):430-433. doi: 10.1016/j.amjsurg.2019.10.015. Epub 2019 Oct 11.

Abstract

Background: The majority of women who undergo genetic testing due to a significant family history of breast cancer will receive a negative result. The purpose of this study was to calculate the lifetime risk of breast cancer in women undergoing genetic counseling who received an uninformative genetic test result.

Methods: A retrospective chart review of mutation-negative women presenting to a cancer risk assessment clinic was performed. Lifetime risks of breast cancer were calculated using the Claus, Gail, and Tyrer-Cuzick risk assessment models.

Results: Approximately half (51%) of the women were classified as high-risk by at least one risk assessment model. The Tyrer-Cuzick model identified the highest proportion (43.2%) of patients as high-risk. Four percent (n = 4) of the sample was considered high-risk by all three models.

Conclusions: More than half (51%) of women who underwent genetic counseling and received an uninformative negative genetic test result had a significantly elevated risk for the development of breast cancer. It is, therefore, imperative that women do not conclude that a negative genetic test result represents a lack of risk.

Keywords: Breast cancer risk assessment; Genetic counseling; High-risk; Negative result; Uninformative result.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / genetics*
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Humans
  • Kansas
  • Middle Aged
  • Neoplastic Syndromes, Hereditary / genetics*
  • Retrospective Studies
  • Risk Assessment*